Cytochalasin D disruption of actin filaments in 3T3 cells produces an anti-apoptotic response by activating gelatinase A extracellularly and initiating intracellular survival signals  by Ailenberg, Menachem & Silverman, Mel
Cytochalasin D disruption of actin filaments in 3T3 cells produces an
anti-apoptotic response by activating gelatinase A extracellularly and
initiating intracellular survival signals
Menachem Ailenberg, Mel Silverman*
CIHR Group in Membrane Biology, Department of Medicine, Room 7207, Medical Science Building, University of Toronto,
Toronto, Ontario, Canada M5S 1A8
Received 14 May 2002; received in revised form 8 November 2002; accepted 22 November 2002
Abstract
Disruption of actin filaments affects multiple cell functions including motility, signal transduction and cell division, ultimately
culminating in cell death. Although this is the usual sequence of events, we have made the interesting observation that disruption of actin
filaments by the potent toxin cytochalasin D (Cyto D) causes one cell type, mouse mesangial cells (MMC), to undergo apoptosis, while in
another cell type (NIH 3T3), it has the opposite effect, resulting in production of survival signals. The purpose of this study was to investigate
the molecular basis for these observed differences. In the present communication, we demonstrate that exposure to Cyto D induces the
pro-apoptotic pathways, p38 and stress-activated protein kinase (SAPK)/jun amino-terminal kinase (JNK), in both cell types. However,
in 3T3, but not MMC, the extracellular signal regulated kinase (ERK) 1/2 pathway is protected from inhibition following treatment with
Cyto D—leading to phosphorylation of Bclxi/Bcl 2-associated death promoter (BAD). Inhibition of Cyto D-induced secretion and activation
of gelatinase A in 3T3 cells reverses the production of survival signals by Cyto-D. To investigate this effect further we employed CS-1 cells,
a well-characterized melanoma cell line that lacks integrin h3, and also does not secrete gelatinase A. Co-transfection of CS-1 cells with
integrin h3 and a gelatinase A transgene, which enables the cells to secrete constituitively active gelatinase A, enhances CS-1 cell survival
signals. Together, our findings suggest that extracellularly activated gelatinase A, through interaction with integrin aVh3, elicits survival
signals mediated through ERK 1/2 that override activation of p38 and SAPK/JNK stress pathways.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
There is intriguing evidence of a functional linkage
between extracellular matrix (ECM) remodeling, brought
about by various proteinases, and tissue specific apoptosis
during organ development [1]. However, the outside–inside
cell signaling pathways by which this occurs remain largely
unknown. Activation of gelatinase A has also been impli-
cated in the initiation of proliferation, differentiation and
cell survival signals, through degradation of ECM compo-
nents and release of growth factors from the ECM reservoir
[2–5]. Thus there is considerable interest as to how ECM
remodelling influences tissue response to inflammation and
the development of sclerosis.
Actin filaments are implicated in transducing signals into
cells by connection to focal adhesion molecules such as
integrins, vinculin and talin [6–9]. Thus, disruption of actin
filaments leads to severe impairment in cell function,
culminating in cell death [10–13]. The potent toxin cyto-
chalasin D (Cyto D) is a specific reagent that causes
disruption of actin filaments by binding to the barbed (plus)
end of growing actin filaments, inhibiting polymerization
[14]. It provides a valuable tool for investigating the func-
tional roles of actin filaments.
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Gelatinase A (mmp-2; Collagenase IV), a member of the
metalloproteinase family, is a proteolytic enzyme that cat-
alyses degradation of extracellular matrix components, most
notably Collagen IV. This enzyme is activated in various
cell types following Cyto D-induced disruption of actin
filaments [15–18]. Gelatinase A has been implicated in the
regulation of numerous cell biological processes and in the
pathogenesis of disease states such as cancer [19] and
glomerulonephritis [2,20]. Recently, gelatinase A has also
been shown to play a role in apoptosis [3–5], EGF receptor
activation [21] and cell proliferation [2]. Integrin aVh3
participates in localization of active gelatinase A to the
plasma membrane [22], and binding of gelatinase A to
aVh3 appears to be necessary for its functional activity
[23].
The present study was undertaken following a chance
observation in our laboratory made during the process of
characterizing the effects of serum-induced starvation on the
induction of apoptosis in different cell types. It is well
known that serum deprivation leads to apoptosis [24]. We
found that Cyto D treatment of serum-starved MMC (which
causes cytoskeletal disruption), as expected, leads to marked
enhancement in caspase 3 activity. But, surprisingly, in
serum-starved 3T3 cells, Cyto D exposure reduces caspase
3 activity. We have investigated the detailed molecular basis
for this phenomenon, and now provide evidence that Cyto
D-induced survival signals in 3T3 cells are mediated
through the extracellular signal regulated kinase (ERK) 1/2
pathway, resulting in phosphorylation of Bclxi/Bcl 2-asso-
ciated death promoter (BAD). Moreover, activation of this
survival pathway overrides the pro-apoptotic p38 and stress-
activated protein kinase (SAPK)/jun amino-terminal kinase
(JNK) pathways. We further demonstrate that the responsible
initiator of the survival signals is extracellularly activated
gelatinase A.
2. Materials and methods
2.1. Cell culture
NIH/3T3 fibroblast cells, human skin fibroblasts (hSF),
rat embryonic fibroblast (RAT 2), MDCK cells and mouse
mesangial cells (MMC) were purchased and maintained in
culture media as recommended (ATCC, Rockville, MD).
Rat mesangial cells (RMC) were isolated as described
earlier [16] and immortalized by transfection with vector
pSV3-neo containing large T antigen (ATCC). RMC were
maintained in D-MEM containing 15% fetal bovine serum
(FBS; Gibco BRL, Burlington, ON) and 400 Ag/ml genet-
icin (Gibco BRL). Similar to primary cultured rat mesangial
cells, the immortalized RMC express vimentin and desmin,
and are negative for cytokeratin 8. Unlike primary cultured
RMC, immortalized RMC do not secrete gelatinase A.
MDCK cells do not secrete gelatinase A, but do secrete
gelatinase B.
CS-1 cells were transfected with integrin h3 subunit
(CS-1 and CS-1-h3 cells were a generous gift of Dr. David
Cheresh, The Scripps Institute, La Jolla, CA) and maintained
in RPMI 1640 containing 5% FBS and 400 Ag/ml G418.
CS-1 cells grow in suspension and become anchorage-
dependent after h3 transfection [22,25]. These cells fail to
produce significant quantities of gelatinase A [22,26] (Fig.
9B). To generate cell lines that secrete active gelatinase A in
a constitutive manner, both cell types were transfected with
plasmid pcDNA3.1/Zeo(+) (Invitrogen, Carlsbad, CA) con-
taining the sequence of human gelatinase A with a 30-bp
sequence of furin substrate sandwiched between the pro and
the active segments of the enzyme (Fig. 9A; FG). NotI
fragment of FG was cut from pOPRSVIFG plasmid [27]
and ligated into the NotI site of dephosphorylated plasmid
pcDNA 3.1/Zeo(+) to yield plasmid pcDNA3.1/Zeo(+)FG.
Both CS-1 and CS-1 h3 cells were stably transfected with
Fig. 1. Influence of Cyto D on caspase 3 activity in MMC and 3T3 cells.
Cells were maintained in serum-free media and processed as described in
Section 2. For kinetic studies, cells were treated with 1 Ag/ml Cyto D and
lysed at the indicated time after treatment. For dose– response studies in
3T3 cells (panel C), cells were treated with the indicated concentrations of
Cyto D and lysed after 5 h. Cyto D treatments are significantly ( P < 0.001;
n= 3) different from the nontreated control.
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the FG-containing construct or vector alone as control, using
Lipofectamin reagent (Gibco BRL) as previously described
[28]. Transfected cells were maintained in the abovemen-
tioned media containing 400 Ag/ml Zeocin (Invitrogen).
2.2. Western blots
Cells were plated in 100-mm plates at density of 5 106
cells/ plate. The next day, cells were washed with Hanks
Balanced Salt solution (HBSS; Gibco BRL) and pretreated
with test reagents for 30 min in the appropriate media,
followed by treatment with Cyto D for 4 h. Antibodies used
were against the proteins in their phosphorylated or non
phosphorylated state (NEB, Mississauga, ON). After docu-
mentation, nitrocellulose paper was striped with 0.5 N NaOH
and re-probed with antibody against the native protein.
Western blots were carried out according to the manufactur-
er’s recommendation, using ECL reagent (Amersham Phar-
macia Biotech, Baie d’Urfe, QU). Different cell types secrete
different basal levels of the phosphorylated proteins. There-
fore, films were exposed for varying times (5–60 s) to ensure
comparison in the linear range of the signal. Hence, different
phosphorylated proteins levels of the various cell types
reported in this study reflect merely different film exposure
time rather than differences in the protein levels.
2.3. Caspase 3 assay
Cells were plated in 24-well plates at the density of
2 105 cells/well in serum-containing medium. The next
day, cells were washed and transferred to serum-free
medium for varying periods of time. Triplicate samples as
described in Section 2.2 were lysed at the indicated times.
Caspase 3 levels were detected in duplicate in cell extract
using a specific caspase 3 fluorogen substrate according to
the manufacturer’s instructions (Ac-DEVD-AMC; Pharmin-
gen, Mississauga, ON).
2.4. Determination of cell viability
Cell viability was determined as described previously
[29]. Anchorage-dependent cells were plated in 24-well
plates in serum-containing media. After 24 h, cells were
washed and when applicable were pretreated with reagent to
be tested for 30 min, followed by treatment with 1 Ag/ml
Cyto D in serum-free media for the time indicated in
legends to figures. Cells were washed, and incubated for 2
h at 37 jC with MTT reagent (Triazol blue; Sigma, Oak-
ville, ON) in HBSS. The MTT reagent was removed and
cells were lysed with 0.5-ml DMSO by shaking for 30 min
at room temperature. One-hundred-microliter aliquots in
duplicates were monitored at 570 nm. Viability of CS-1
cells (that grow in suspension) was carried out similarly,
except the procedures were performed in quadruplicate in
15-ml tubes by centrifugation and resuspension according to
need.
2.5. SDS/PAGE zymography
Gelatinolytic activity in conditioned media was detected
using SDS/PAGE zymography as previously described [16].
When required, conditioned media were concentrated by
dialysis and lyophilization. Although activation of gelati-
nase Awith Cyto D is evident as early as 2 h after treatment
([30]; Ailenberg and Silverman, unpublished data), in the
present study, we report on the zymographic pattern in
conditioned media 24 h after Cyto D treatment.
2.6. Statistical analysis
Each protocol was repeated at least three times, and for
every experiment, observations were made in triplicates or
quadruplicates. Figures show representative experiments.
Difference between means was evaluated using Student’s t
test.
Fig. 2. Effect of Cyto D on activation of gelatinase A in MMC and 3T3 cells. Cells were treated with Cyto D for 24 h in serum-free media and gelatinolytic
activity was monitored in straight conditioned media of MMC and 3T3 cells (A) or 40 -concentrated MMC (B) conditioned media. Both MMC and 3T3 cells
secrete latent gelatinase A (upper arrows in panels A and B). 3T3 cells respond to Cyto D by secreting also the active and the intermediate forms of gelatinase A
(panel A, lane 4, lower and middle arrows, respectively). In contrast, no gelatinolytic band of active gelatinase A is observed in MMC even after concentration
of the conditioned medium (lane 2 in both panels).
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3. Results
3.1. Differential effects of Cyto D on MMC and 3T3
viability and caspase 3 activity
In the presence of serum-free medium, treatment of
MMC with Cyto D causes the cells to round up. There is
a general manifestation of cell distress, accompanied after
24 h by a marked reduction (up to 80%) in cell viability.
Exposure of 3T3 cells to Cyto D also causes them to round
up, but in contrast to MMC, 3T3 cells become resistant to
serum starvation-induced apoptosis as reflected in a f 50%
increase in the MTT assay (data not shown).
To explore the molecular basis underlying the unexpected
Cyto D-induced protection against apoptosis in 3T3 cells as
documented above, we first examined the kinetics of caspase
3 activity (which occurs early in the apoptotic response,
before any changes in cell viability are observed) in both
MMC and 3T3 cells. Caspase 3 activity was measured,
following serum withdrawal, in the absence (control) and
presence of Cyto D. As demonstrated in Fig. 1, caspase 3
levels progressively increased in Cyto D-treated MMC
(panel B), while in 3T3 cells (panel A), caspase 3 levels
remained low compared to untreated controls. After 24 h,
caspase 3 activity in both cell types returned to their
respective basal levels. Moreover, the Cyto D effect on
3T3 cells was dose-dependent (panel C). A similar pattern
of caspase 3 activity was observed when apoptosis was
initiated by camptothecin, a pro-apoptotic agent, that exerted
its action through inhibition of topoisomerase I ([31,32]; data
not shown). In summary, caspase 3 levels measured only a
few hours after Cyto D treatment, reflect commitment of the
cells, either to undergo or resist, serum starvation-induced
apoptosis, which eventually becomes manifest 24 h later.
3.2. Evidence that Cyto D survival effect is linked to active
gelatinase A
Cyto D treatment of various cell types stimulates secre-
tion and activation of gelatinase A [15–18]. Using zymog-
raphy we found, as expected, that exposure of 3T3 cells to
Cyto D results in secretion and activation of Gelatinase A,
but in sharp contrast, there is absolutely no evidence of
gelatinase A activation when MMC are similarly treated
(Fig. 2). Based on these findings, we reasoned that active
gelatinase A might be a potential candidate to reconcile the
differential effect of Cyto D on survival of MMC and 3T3
cells. We therefore investigated whether the anti-apoptotic
Cyto D effect in 3T3 cells was altered by the presence of a
selective gelatinase A inhibitor: MMP-2 inhibitor I (Calbio-
chem, San Diego, CA). This agent is known to inhibit
gelatinase A in a dose-dependant manner [33–35]. As
documented in Fig. 3A, with increasing inhibitor concen-
tration, the anti-apoptotic effect of Cyto D is reversed. Of
note, f 50% inhibition was achieved by 4–5 AM of the
inhibitor which correlates reasonably well with the f 1–2
AM required for 50% inhibition of gelatinase A in vitro.
Moreover, as revealed in Fig. 3B, exposure to this drug has
no effect on cell viability at 5 h (when the caspase 3 activity
was monitored).
Fig. 3. Effect of MMP-2 inhibitor I on anti-apoptotic action of Cyto D in
3T3 cells. Cells were maintained in serum-free media as described in
Section 2, pre-incubated with various concentrations of the selective MMP-
2 inhibitor I for 30 min, followed by treatment with 1 Ag/ml Cyto D for 5 h.
Caspase 3 activity is shown in panel A and viability of the cells is in panel
B. Note that the anti-apoptotic effect of Cyto D (panel A) is gradually
diminished as the concentrations of the inhibitor increase. Panel B: No
change in cell viability is noticed 5 h after all treatments were employed.
Panel A—Cyto D treatments (except at 20 AM inhibitor) are statistically
different from the corresponding controls (0 inhibitor—P < 0.001, 5 AM
inhibitor—P < 0.005; n= 3). Bars indicate mean plus S.E.
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To determine the universality of the response of various
cells to Cyto D, we monitored the zymographic pattern,
caspase 3 levels and ERK 1/2 phosphorylation state in six
different cell types. As documented in Fig. 4, cells could be
categorized into three groups: (i) Group I (pro-apoptotic)
responded to Cyto D with an increase in caspase 3 activity
and reduction in phosphorylation of ERK 1/2. These cells
do not express active gelatinase A after treatment with Cyto
D, either because they do not secrete any gelatinase A as in
the case of RMC shown in the upper right hand panel of Fig.
4, or because they secrete latent gelatinase A, but do not
respond to Cyto D by activation of the enzyme as is the case
for MMC. MDCK cells secrete only gelatinase B; (ii) Group
II (non-apoptotic) exhibit no change in caspase 3 and ERK
1/2 phosphorylation levels. hSF cells secrete active gelati-
nase A under basal conditions. Treatment with Cyto D
produces only a marginal enhanced expression of active
gelatinase A compared with the non treated control; and (iii)
Group III (anti-apoptotic) demonstrate reduced caspase 3
levels and increased ERK 1/2 phosphorylation. Both cell
types (3T3, RAT2) respond to Cyto D by activation of
gelatinase A.
3.3. Phosphorylation of mitogen-activated kinases (MAPKs)
and BAD
In order to assess the mechanism of action of Cyto D-
induced gelatinase A on cell survival, we next undertook a
series of experiments to help define the intracellular signal-
ing events involved. We compared the phosphorylation state
of MAPKs and BAD in 3T3 cells and MMC following
treatment with Cyto D. In MMC, phosphorylation of both
members of the ERK pathway, MAPK/ERK kinase (MEK)
1/2 and ERK 1/2, is reduced while phosphorylation of the
stress pathways, p38 and SAPK/JNK, is increased (Fig. 5).
By contrast, in 3T3 cells, phosphorylation of ERK 1/2 and
MEK 1/2 is increased following treatment with Cyto D, and
similar to MMC, phosphorylation of the stress pathways
Fig. 4. Screening various cell types for the effect of Cyto D on caspase 3, Phospho ERK 1/2 and metalloproteinases levels. Cells were maintained and treated
with Cyto D in serum-free media as indicated in Section 2 and lysed after 4 or 5 h for Western blots or caspase 3 assays, respectively, or conditioned media
were collected 24 h after treatment for zymography. Three main groups can be noted: Group I—MDCK, MMC and RMC respond with an elevation in caspase
3 levels, and a decline in P-ERK 1/2 levels of representative cells MMC. Cyto D produces pro-apoptotic signals in this group. These cells do not secrete active
gelatinase A in response to cyto D (note: gelatinolytic pattern of conditioned medium from Cyto D-treated hSF is also shown for orientation purposes). Group
II—hSF show no increase in caspase 3 and P-ERK 1/2 levels following treatment with Cyto D. hSF in group II secrete high basal levels of active gelatinase A
which is slightly enhanced following treatment with Cyto D. group III—3T3 and RAT 2 cells respond to Cyto D with a decrease in caspase 3 and an increase in
P-ERK 1/2 levels in representative 3T3 cells. Cyto D produces anti-apoptotic signals in this group. Group III cells (3T3, RAT 2) respond to Cyto D with a
strong activation of gelatinase A. Arrowheads denote migration position of active gelatinase A. In Western immunoblots, nitrocellulose membrane were
stripped and re-probed with anti-ERK 2 antibody. Cyto D treatments are statistically different ( P < 0.001; n= 3) from the nontreated controls, except ‘RMC’
(group I—P < 0.05; n= 3) and ‘hSF’ (Group II—not significant). Bars represent mean plus S.E.
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proteins p38 and SAPK/JNK is also increased. Since the
outcome in 3T3 cells treated with Cyto D is enhanced cell
survival, these results suggest that the observed activation
(as reflected in increased phosphorylation) in the ERK 1/2
pathway overrides the pro-apoptotic signaling usually ini-
tiated by activating the p38 and the SAPK/JNK pathways.
Inhibition of p38 MAPK with SB 203580 did not change
the Cyto D effect on either MMC or 3T3 cells (data not
shown). To asses more directly the role of active gelatinase
A in producing the anti-apoptotic effect in 3T3 cells, the
selective MMP-2 Inhibitor I was used. As shown in Fig. 6,
inhibition of Cyto D-induced active gelatinase A activity by
the selective MMP-2 Inhibitor I, inhibits phosphorylation of
ERK 2, further suggesting that the anti-apoptotic effect of
active gelatinase A is exerted through the ERK pathway.
A similar pattern of phosphorylation was observed for
the pro-apoptotic protein BAD. Following treatment with
Cyto D, the phosphorylation of BAD was decreased in
MMC, and increased in 3T3 cells (Fig. 7).
Taken together, these results imply that in 3T3 cells, Cyto
D increases phosphorylation of BAD through activation of
the ERK 1/2 pathway, leading to an anti-apoptotic stimulus.
Finally, the Cyto D pro-apoptotic effect in MMC, and its
anti-apoptotic effect in 3T3 cells, remain unaltered in the
presence of both staurosporine and LY294002 (Fig. 8),
Fig. 5. Western immunoblots for MAPKs and MEK 1/2 in MMC and 3T3 cells following treatment with Cyto D. Cells were plated in 100-mm dishes and
maintained for 24 h in serum-containing media. Cells were washed and treated with (panels A–C, lanes 2, 4, 6, 8; panel D, lanes 2, 4) or without (panels A–C,
lanes 1, 3, 5, 7; panel D, lanes 1, 3) 1 Ag/ml Cyto D. Cells in panels A–C lanes 3, 4, 7, 8 were treated in serum-containing media. Other cells were treated in
serum-free media. Cells were lysed after 4 h and blotted with anti phospho-specific antibodies (indicated by the letter P). Blots were stripped and re-probed with
antibodies against the non-phosphorylated proteins. 3T3 cells: panels A–C: lanes 1–4, panel D: lanes 1, 2. MMC: panels A–C: lanes 5–8, panel D: lanes 3, 4.
Fig. 6. Effect of MMP-2 Inhibitor I on phospho ERK 2 levels in 3T3 cells.
Cells were maintained in serum-free media, treated as indicated in Fig. 5
and probed with anti phospho ERK-2 antibodies (P-ERK-2). Blots were
stripped and re-probed with anti-ERK 2 antibodies (ERK-2). Note that
inhibition of Cyto D-induced active gelatinase A with 20 AM of the
selective inhibitor causes inhibition in phosphorylation of ERK-2.
Fig. 7. Western immunoblot for BAD of MMC and 3T3 cells following
treatment with Cyto D. Cells were maintained in serum-free media, treated
as indicated in Fig. 5, and blotted with anti phospho-specific (P) antibodies
for BAD. Blots were stripped and re-probed with anti-BAD antibodies.
Note that phospho-BAD levels are elevated in 3T3 cells and reduced in
MMC following treatment with Cyto D.
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suggesting that the Cyto D-induced gelatinase A activation
extracellularly initiates an intracellular signaling pathway
that bypasses PKC and PI3Kinase.
3.4. Evidence that gelatinase A effects are mediated through
integrin Vb3
Integrin aVh3 has been implicated in extracellular bind-
ing of active gelatinase A to the plasma membrane [22]. We
therefore sought a suitable experimental model system to
prove directly that active gelatinase A mediates its action
through integrin aVh3. This was achieved by introducing
furin substrate between the pro and active segments of
human gelatinase A (Fig. 9A). Upon passage in the Trans
Golgi Network (TGN), transgenic protein is cleaved by the
membrane-anchored furin enzyme, a resident of the TGN.
Gelatinase A is then secreted in active form [28]. However,
both MMC and 3T3 cells are not good candidates for this
experiment, since 3T3 cells secrete endogenous gelatinase
that could potentially mask the transgene effect, and MMC
do not localize active gelatinase A to their plasma mem-
brane [36], which is a prerequisite for its action.
To get around some of these obstacles, we selected a
well-characterized experimental hamster melanoma cell line
CS-1 for transfection studies. These cells do not secrete
gelatinase A (Fig. 9B, lanes 1 and 2), but have been shown
to localize exogenous active gelatinase A to their plasma
membrane after transfection with integrin h3 subunit [22].
Accordingly, CS-1 and CS-1-h3 cells were each transfected
with the FG construct depicted in Fig. 9A. Inspection of Fig.
9B, lanes 3 and 4, indicates that following transfection, both
cell types secrete active gelatinase A into the conditioned
media as revealed by SDS-zymography. For comparison, in
Fig. 9, lane 5, we demonstrate the gelatinolytic pattern of
conditioned medium from 3T3 cells following exposure to
Cyto D. Note the two additional higher molecular weight
gelatinolytic bands in the conditioned medium of the FG-
Fig. 8. Influence of PKC and PI3K inhibitors on the effect of Cyto D on
Caspase 3 activity in MMC and 3T3 cells. Cells were maintained in serum-
free media as indicated in Section 2, pre-incubated with 10 AM of the
inhibitors for 30 min and treated with 1 Ag/ml Cyto D for 5 h. Note that
while each inhibitor is able to induce caspase 3 levels, they are not able to
block the Cyto D effects on the corresponding cells, i.e. decrease in 3T3
cells (panel A) and increase in MMC (panel B). Cyto D treatments are
statistically different ( P < 0.001; n= 3) from the nontreated corresponding
controls, except ‘No Drug’ (panel A—P< 0.025; n= 3) and ‘Staurosporine’
(panel B—P< 0.05; n= 3). Bars indicate mean plus S.E.
Fig. 9. Secretion of active gelatinase A by transfected CS-1 cells. Panel A:
Schematic representation of the Furin-Gelatinase A (FG) construct. Furin
substrate sequence (box) was introduced between the pre and the active
segments (solid line) of gelatinase A using the staggered reannealing
method. Numbers indicate bases in the construct and arrowheads indicate
location of sequence for NotI and BclI restriction enzymes. Arrow below
the line indicates cleavage site of furin. Arrows above the line indicate
position of two primer pairs used in PCR to amplify the 5Vand the 3V
segments that were cut with BclI and ligated to form the full-length FG
construct. (For further details see Refs. [27,28,35].) Panel B: Cells were
maintained in serum-free medium for 24 h, collected and subjected to SDS/
PAGE zymography. CS-1 cells with (lanes 2 and 4) or without (lanes 1 and
3) h3 integrin subunit were transfected with plasmid pcDNA 3.1Zeo(+)
with (lanes 3 and 4) or without (lanes 1 and 2) FG construct, and
conditioned media were subjected to SDS/PAGE zymography. For
comparison, conditioned medium from Cyto D-treated 3T3 cells (lane 5)
is shown. Arrow indicates migration of active gelatinase A. Note that both
FG-transfected cells (lanes 3 and 4) secrete active gelatinase A, while vector
alone-transfected cells do not exhibit any detectable gelatinolytic bands
(lanes 1 and 2). Note also two additional higher molecular bands in FG-
transfected cells. Conditioned media were loaded on gel straight (lanes 4
and 5) or after 10 (lanes 1–3) concentration.
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transfected cells. These bands react in immunoblots with
gelatinase A-specific antibody (data not shown) and prob-
ably represent unprocessed full construct and/or a dimer of
gelatinase A. The conditioned media also exhibits proteo-
lytic activity when measured with the proteinase substrate
azocol (data not shown).
Fig 10 clearly demonstrates that the gelatinase A effect is
mediated through integrin aVh3. It should be noted that no
change was detected in the MTT assay when active gelat-
inase A was transfected into CS-1 cells lacking the h3
subunit (Fig. 10).
4. Discussion
The cytoskeleton, together with its attached focal adhe-
sions and extracellular matrix (ECM), forms a unique
communication unit allowing transmission of chemical
signaling information into and out of cells [6,8,9]. Abnor-
mal function of any of the components of this structured
network, including the actin filaments, can lead to cell
death. It is not surprising, therefore, that when the actin
filaments of MMC were disrupted by Cyto D, the cells
underwent apoptosis. Unexpectedly, however, in 3T3 cells,
treatment with Cyto D rendered these cells resistant to
apoptosis induced by serum starvation. The results of the
present study indicate that the paradoxical, anti-apoptotic
effect of Cyto D observed is a consequence of Cyto D-
induced activation of gelatinase A.
In terms of the signaling pathways that were stimulated
by exposure to Cyto D, induction of apoptosis in MMC was
accompanied by enhanced phosphorylation of the stress
pathways (p38, SAPK/JNK) and decreased phosphorylation
of the survival pathways (ERK, BAD). The cumulative
effect of these molecular events was an increase in caspase
3 levels and cell death. On the other hand, in the case of 3T3
cells, Cyto D exposure had the opposite effect—causing
increased phosphorylation of MEK 1/2, ERK 1/2 and
BAD—and presumably this was the basis for decreased
caspase 3 levels and cell survival. Since phosphorylation of
p38 and SAPK/JNK was also increased following treatment
of 3T3 cells with Cyto D, our data further suggest that the
induction of ERK 1/2 and the anti-apoptotic pathways is
sufficient to override the deleterious effects induced by
activation of cell stress pathways.
It has been demonstrated that p90RSK (a substrate for
ERK 1/2) phosphorylates BAD and prevents apoptosis [37–
40]. In the present study, we found that Cyto D treatment
resulted in decreased phosphorylation of BAD in MMC, but
an increase in phosphorylation in 3T3 cells. Activation of
this signaling cascade could explain the anti-apoptotic
action of Cyto D.
But is there a link between Cyto D-induced actin
filament disruption and stimulation of the survival signaling
cascade described above? Evidence from the present study
indicates that the survival signals originate from active
gelatinase A, because inhibiting gelatinase A activity
reverses the Cyto D anti-apoptotic effect; and transfection
of CS-1-h3 cells with active gelatinase A suggests that the
active gelatinase effect is mediated through integrin aVh3.
We and others have shown that gelatinase A is activated
following disruption of actin filaments by Cyto D [15–18].
But the mechanism by which this occurs is not clear. Other
laboratories have also implicated active gelatinase A in
processes such as proliferation, differentiation and cell
survival on the basis of degradation of ECM components
and release of growth factors from the ECM reservoir [2–5].
But the role of activated gelatinase A in stimulating survival
signaling may not arise from an effect on the ECM alone,
but may instead involve interaction of activated gelatinase A
with the cell surface. In this regard, Brooks et al. [22] have
demonstrated that integrin aVß3 specifically binds active
gelatinase A. Silletti and Cheresh [41] speculated that
integrin aVß3 may be involved in the activation complex
of gelatinase A. It is possible that functional differences of
this integrin between MMC and 3T3 cells may be the reason
for an inability to localize activated gelatinase A to MMC
plasma membrane.
In the present manuscript we have demonstrated by
transfection of CS-1 cells with active gelatinase A that it
exerts its action through integrin aVh3. Expression of this
integrin renders the cells anchored to the substratum. It is
possible that differences in how active gelatinase A influ-
ences the two CS-1 cell types are a consequence of their
anchorage capabilities. However, it seems more likely that
the effects of activated gelatinase A are mediated through
binding to integrin aVh3 as reported by Brooks et al. [22].
Fig. 10. MTT assay of CS-1 cells in culture. Cells were plated in serum-
containing medium for 24 h. Cells were washed 3 with serum-free
medium, maintained for 0, 1, 2 and 3 days in serum-free media and assayed
at the times indicated using the MTT assay. Results were normalized to the
corresponding vector alone-transfected cells. Asterisk denotes statistical
difference (at least P < 0.05) of FG-transfected CS-1-h3 cells from the
vector alone-transfected cells.
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Elucidation of the mechanism involved will require future
detailed molecular investigation.
In summary, we have documented an intriguing role for
activated gelatinase A in regulating the balance between
initiation and inhibition of programmed cell death. It
appears that in certain cells, this is accomplished through
interaction of active gelatinase A mediated through a cell
surface component, possibly integrin aVh3. This is fol-
lowed by the stimulation of intracellular signaling involving
ERK 1/2-dependent pathway, which opposes, and under
certain conditions overrides, simultaneous signaling through
p38 and SAPK/JNK cascades. One of the possible implica-
tions is that regardless of the stimulus of metalloproteinase
activation, such as might occur in response to an increase in
matrix synthesis, the response may be more than a simple
increase in matrix degradation. Instead, gelatinase A may
affect cell number through regulation of programmed cell
death.
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